SBSantosh Kumar Behera

Santosh Kumar Behera

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Santosh Kumar Behera has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integrative computational, ethnomedicinal and system pharmacology approach to decipher the anti-diabetic potential of Mangifera indica L. phytochemicals

    by S T Chandra, K B Santosh, K P Amrita, P Sagarika

    The global increase in adult Type 2 diabetes mellitus (T2DM) cases is attributed to unhealthy diets, insufficient physical activity and increased work pressure, leading to elevated glucose levels. Human dipeptidyl peptidase 4 (DPP-4) regulates post-prandial insulin release, with increased bioavailability resulting from inhibition and increased Glucagon-Like Peptide-1 (GLP-1) levels. The NAD(H)/NAD ratio affects 11-beta-hydroxysteroid dehydrogenase 1 (HSD11B1), which converts cortisone to cortisol. It promotes glucose metabolism by increasing phosphoenolpyruvate carboxykinase (PEPCK) transcription. The present study aims to identify novel lead compounds from Mangifera indica L. for T2DM therapies that could inhibit key targets DPP-4 and HSD11B1, overcoming current medication limitations. 14 phytocompounds were screened from 63 and docked against the key targets DPP-4 and HSD11B1. To evaluate the reactivity and properties of the potential molecules, a quantum-mechanical simulation was performed using an arbitrary postulate of density functional theory (DFT). The phyto-compound kaempferol exhibited higher interaction with better binding affinity against T2DM targets DPP-4 and HSD11B1 out of 14 screened phyto-constituents, followed by other compounds. Kaempferol showed optimal binding energies of -7.6 and -9.0 kcal mol-1 for DPP-4 and HSD11B1, respectively, compared with the standard drug metformin. Subsequently, kaempferol exhibited higher reactivity than the standard per quantum-chemical calculations. The molecular dynamics (MD) simulation studies of complexes with kaempferol demonstrated stable, consistent dynamics over a specific period. The results suggest that natural compounds from mango leaves may represent a promising approach for developing new therapies, potentially reducing reliance on conventional drug discovery procedures.

  • Open Access

    Impact of bio-computational tools for early detection of competent drug possibilities from Zingiber officinale Roscoe against adiponectin protein of type 2 diabetes mellitus and cardiovascular disease

    by Chandra Sekhar Tripathy, Santosh Kumar Behera, Sagarika Parida

    Introduction: Dysbiosis of adiponectin is linked with an unhealthy gut microbiome resulting a decrease in the amount of adiponectin that induces type 2 diabetes mellitus (T2DM), obesity, dyslipidemia, thrombophilia, and cardiovascular disease (CVD). CVD, particularly stroke and heart attacks, is the prime reason for death among T2DM patients due to lower amounts of adiponectin, expressed by the gene ADIPOQ. Lower levels of adiponectin are strongly connected with insulin resistance and hyperinsulinemia. Research on the relationship between adiponectin and obesity, T2DM, and CVD is limited and the gaps need to be explored. Considering the importance of adiponectin, the current investigation was carried out through the screening of the phytocompounds from Zingiber officinale Roscoe against adiponectin to find out the potent phytocompounds for enhancing the production of adiponectin. Methods: In silico investigation approaches such as Lipinski’s rule of five, network analysis molecular docking, and molecular dynamics simulations were performed to explore the impact of adiponectin in T2DM and CVD comorbidities and its therapeutics. Results: Fifteen out of 24 compounds satisfied Lipinski’s rule of five that were further processed in various in silico studies along with the standard metformin. The docking studies revealed that the compound galanolactone with the highest binding affinity of -7.0 kcal/mol against Adiponectin was better than metformin. Conclusion: The bio-computational tools explored an effective natural compound galanolactone identified with better efficacy than metformin in enhancing the levels of adiponectin that might ultimately be beneficial in the treatment of T2DM and CVD.

  • In silico investigation of human GLP-1 for diabetic nephropathy and in-vitro and in-vivo evaluation of its formulation

    by Shraddha Baviskar, Tejas Girish Agnihotri, Shivani Khopade, Sanghamitra Pati, Santosh Kumar Behera, Aakanchha Jain


  • Open Access

    Computational investigations of bio-active phytoconstituents from Chamaecostus cuspidatus (Nees & Mart.) C. Specht & D.W. Stev. against peroxisome proliferator-activated receptor gamma (PPARG) protein of type 2 diabetes mellitus

    by Tripathy Chandra Sekhar, Behera Santosh Kumar, Parida Sagarika

    Abnormalities in the body's propensity to control and take advantage of sugar as fuel result in type 2 diabetes mellitus (T2DM). Targeting the transcription factor peroxisome proliferator-activated receptor gamma (PPARG) protein, which controls the expression of proteins critical to the progression of type 2 diabetes mellitus (T2DM), is an intriguing approach for treating T2DM. Therefore, the current study focuses on predicting more effective natural compounds for better treatment. Chamaecostus cuspidatus (Nees & Mart.) C. Specht & D. W. Stev. belonging to the family Costaceae, traditionally acknowledged as an insulin herb, has been taken for the study. Phytocompounds were collected from the published literature, followed by in silico ADMET toxicity checking and molecular docking study against the PPARG protein at its specific binding sites. A quantum computation study was performed to check the reactivity of the ligands and normal mode analysis (NMA) was employed to study and characterize the selected protein's flexibility and stability with network analysis. Anti-diabetic drug Biguanide (Metformin) was taken as a standard drug. From this study, Kaempferol resulted with a premier imperative affinity of -7.1 kcal/Mol, with the lowest band gap energy that forms one conventional hydro bond with His466, which is suggested as a new drug molecule for T2DM treatment. In molecular dynamics simulation, the natural compound Kaempferol reflected better stability with the target protein PPARG.

  • In‐silico and In‐vitro Investigation of Flavonoids and Alkaloids from Artocarpus heterophyllus, Tinospora cordifolia, and Glycosmis pentaphylla as Potential NF‐κB Inhibitors in Oral Cancer

    by Komal Nagesh Gotsurve, Joyeeta Das, Suraj Kutre, Parusu Kavya Teja, Rajeshwari Rathod, Siddheshwar K. Chauthe, Santosh Kumar Behera

    Oral cancer is a global health concern, particularly because of its aggressive tissue invasion and metastases, holding 16th position on occurrence among all carcinoma worldwide. The aberrated transcription factor NF‐κB1 influences development and spread of oral cancer, making it a potential therapeutic target. This study investigated the therapeutic potential of a few natural compounds from Artocarpus heterophyllus, Tinospora cordifolia, and Glycosmis pentaphylla in the treatment of oral cancer. Two FDA‐approved drugs (5‐fluorouracil, Docetaxel) and 16 natural compounds, including Artocarpin, Artocarpanone, Cycloartocarpin from Artocarpus heterophyllus; Berberine, Hydrastine, Magnoflorine, Palmatine Chloride, Tetrahydropalmatine from Tinospora cordifolia; and 5‐Hydroxyarborinine, 5‐Hydroxynoracronycine, 1‐Hydroxy‐3‐methoxy‐10‐methyl‐9‐acridone, Des‐N‐methylacronycine, Des‐N‐methylnoracronycine, Kokusagenine, Noracronycin, Skimmianine from Glycosmis pentaphylla were examined using in‐silico techniques. Among the 16 natural compounds studied, Hydrastine shown the highest binding energy (−6.87 kcal/mol) against NF‐κB1, surpassing all other drugs, including the standards 5‐fluorouracil (−4.04 kcal/mol) and docetaxel (−2.4 kcal/mol). Further molecular dynamics simulations and in‐vitro experiments verified Hydrastine's exceptional anti‐cancer activity. The results of in‐vitro were well‐aligned with the findings of in‐silico, revealing considerable cytotoxicity, apoptosis induction, and cell cycle arrest. The findings revealed natural compounds’ potential as safer, more effective alternatives to current cancer therapeutics, opening up new avenues for oral cancer treatment.


  • Open Access

    Ethnomedicinal uses of Moringa oleifera Lam. and the phytochemicals in regulating Type 2 Diabetes and inflammation

    by Chandra Sekhar Tripathy, Ananya Mishra, Santosh Kumar Behera, Sagarika Parida

    Leaves and young pods of Moringa oleifera Lam. are not only used as vegetables, but different parts such as stem, stem barks, gum-resin, root, flower, seed pod, pod husk, seeds, and roots are also used in the traditional system of medicine. Chemical compounds such as alkaloids, phenolics, and terpenoids as excretory or waste products are produced by plants through the metabolic pathways. These chemical compounds have antibiotic, antimicrobial, and anti-insecticidal activity for their self-defense from a wide variety of pathogens. The ethnomedicinal uses and the scientific assessment of M. oleifera Lam. are essential, as it is a traditional food with numerous medicinal properties. Moringa leaves are an excellent nutritional supplement that contains crucial amino acids, minerals, vitamins, proteins, and other bioactive phytochemicals. In particular, the high nutrient content of the leaves benefits pregnant women and infants. It is also an effective diabetic, analgesic, and antimicrobial agent. This review mainly highlights the ancient medicinal uses of different plant parts such as leaves, flowers, fruit pods, seeds, seed oil, stem bark, gums, and roots; its mineral contents, phytochemical composition, and pharmacological potential, especially antidiabetic, antimicrobial, and analgesic activity, emphasizing the molecular mechanisms associated with anti-inflammatory and anti-diabetic activity.


  • Pharmacoinformatics approach for type 2 diabetes mellitus therapeutics using phytocompounds from Costus genus: an in-silico investigation

    by Drashti Bhavsar, Suraj Kutre, Priti Shikhare, Sunil Kumar, Santosh Kumar Behera, Siddheshwar Kisan Chauthe

    Diabetes mellitus (DM) is a chronic metabolic disorder characterised by an increase in blood glucose levels. Type 2 Diabetes mellitus (T2DM), results decreased insulin production and increased resi...


  • Open Access

    In Silico Analysis Determining the Binding Interactions of NAD(P)H: Quinone Oxidoreductase 1 and Resveratrol via Docking and Molecular Dynamic Simulations

    by Santosh Behera, Christoffer Lambring, Albina Hashmi, Sriharika Gottipolu, Riyaz Basha

    NAD(P)H: Quinone oxidoreductase1 (NQO1) plays a crucial role in cellular defense against oxidative stress. Overexpression of NQO1 is linked to various cancer pathways. Despite its potential, the actual mechanisms to inhibit NQO1 and increase the efficacy of standard therapeutic options are not yet established. Resveratrol is an anti-cancer polyphenol found in dietary products and red wine. The objective of this investigation is to employ in silico methods to explore how resveratrol interacts with NQO1. Docking analysis of resveratrol against NQO1 was performed using Glide. The most efficiently docked complex was characterized and analyzed by measuring intermolecular (IM) hydrogen (H)-bonds and binding energy values, additional hydrophobic, and electrostatic interactions. IM interaction between complexed protein and compound was demonstrated using LigPlot+ and the Schrödinger ligand interaction module. Molecular dynamics tools were employed to examine the physical movement of molecules to evaluate how macromolecular structures relate to their functions. The results of this investigation depicted a strong affinity of resveratrol against NQO1 followed by MD simulations (NQO1-resveratrol complex-binding energy: −2.847kcal/mol). Resveratrol’s robust binding affinity through docking and molecular dynamic simulations highlights a significant change around 90 ns. The H-bonds number was inversely linked with the resveratrol-NQO1 complex stability. The NQO1-Resveratrol complex displayed dynamic motion, as revealed by porcupine projections, indicating alterations in its movement and flexibility. The present in silico analysis suggests a possible alteration in resveratrol’s orientation in the protein binding pocket. The findings encourage further investigation, including validation using in vitro and in vivo assays.


  • Correction: Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson’s Disease by GLP-1 Secretion

    by Nishant Sharma, Ritu Soni, Monika Sharma, Sayan Chatterjee, Nidhi Parihar, Mohd Mukarram, Ruhi Kale, Adil Ali Sayyed, Santosh Kumar Behera, Amit Khairnar


  • Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson’s Disease by GLP-1 Secretion

    by Nishant Sharma, Ritu Soni, Monika Sharma, Sayan Chatterjee, Nidhi Parihar, Mohd Mukarram, Ruhi Kale, Adil Ali Sayyed, Santosh Kumar Behera, Amit Khairnar

    Parkinson’s disease (PD) is a chronic motor disorder, characterized by progressive loss of dopaminergic neurons. Numerous studies suggest that glucagon-like peptide-1 (GLP-1) secretagogue has a neuroprotective role in PD models. The present study evaluated potential of coffee bioactive compounds in terms of their ability to bind GPR-40/43 and tested the neuroprotective effect of best candidate on rotenone-induced PD mice acting via GLP-1 release. In silico molecular docking followed by binding free energy calculation revealed that chlorogenic acid (CGA) has a strong binding affinity for GPR-40/43 in comparison to other bioactive polyphenols. Molecular dynamics simulation studies revealed stable nature of GPR40-CGA and GPR43-CGA interaction and also provided information about the amino acid residues involved in binding. Subsequently, in vitro studies demonstrated that CGA-induced secretion of GLP-1 via enhancing cAMP levels in GLUTag cells. Furthermore, in vivo experiments utilizing rotenone-induced mouse model of PD revealed a significant rise in plasma GLP-1 after CGA administration (50 mg/kg, orally for 13 weeks) with concomitant increase in colonic GPR-40 and GPR-43 mRNA expression. CGA treatment also prevented rotenone-induced motor and cognitive impairments and significantly restored the rotenone-induced oxidative stress. Meanwhile, western blot results confirmed that CGA treatment downregulated rotenone-induced phosphorylated alpha-synuclein levels by upregulating PI3K/AKT signaling and inactivating GSK-3β through the release of GLP-1. CGA treatment ameliorated rotenone-induced dopaminergic nerve degeneration and alpha-synuclein accumulation in substantia nigra and augmented mean density of dopaminergic nerve fibers in striatum. These findings demonstrated novel biological function of CGA as a GLP-1 secretagogue. An increase in endogenous GLP-1 may render neuroprotection against a rotenone mouse model of PD and has the potential to be used as a neuroprotective agent in management of PD. Graphical abstract